BERRENDERO F
BERRENDERO F
University Francisco de Vitoria
Dirección de correo verificada de ufv.es
TítuloCitado porAño
Involvement of the endocannabinoid system in drug addiction
R Maldonado, O Valverde, F Berrendero
Trends in neurosciences 29 (4), 225-232, 2006
5332006
Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function
T Bisogno, F Berrendero, G Ambrosino, M Cebeira, JA Ramos, ...
Biochemical and biophysical research communications 256 (2), 377-380, 1999
3391999
The endogenous cannabinoid system and brain development
J Fernández-Ruiz, F Berrendero, ML Hernández, JA Ramos
Trends in neurosciences 23 (1), 14-20, 2000
3292000
Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period
F Berrendero, N Sepe, JA Ramos, V Di Marzo, JJ Fernández‐Ruiz
Synapse 33 (3), 181-191, 1999
2451999
Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol
F Berrendero, R Maldonado
Psychopharmacology 163 (1), 111-117, 2002
2292002
Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegeneration
HH Hansen, PC Schmid, P Bittigau, I Lastres‐Becker, F Berrendero, ...
Journal of neurochemistry 78 (6), 1415-1427, 2001
2292001
Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in μ-opioid receptor knock-out mice
F Berrendero, BL Kieffer, R Maldonado
Journal of Neuroscience 22 (24), 10935-10940, 2002
2142002
The endogenous opioid system: a common substrate in drug addiction
JM Trigo, E Martin-García, F Berrendero, P Robledo, R Maldonado
Drug and alcohol dependence 108 (3), 183-194, 2010
1792010
Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9‐Tetrahydrocannabinol …
V Di Marzo, F Berrendero, T Bisogno, S Gonzalez, P Cavaliere, J Romero, ...
Journal of neurochemistry 74 (4), 1627-1635, 2000
1652000
Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development
F Berrendero, L Garcia-Gil, ML Hernandez, J Romero, M Cebeira, ...
Development 125 (16), 3179-3188, 1998
1561998
The endogenous cannabinoid system and the basal ganglia: biochemical, pharmacological, and therapeutic aspects
J Romero, I Lastres-Becker, R de Miguel, F Berrendero, JA Ramos, ...
Pharmacology & therapeutics 95 (2), 137-152, 2002
1482002
Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene
F Berrendero, V Mendizábal, P Robledo, L Galeote, A Bilkei-Gorzo, ...
Journal of Neuroscience 25 (5), 1103-1112, 2005
1432005
Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior
A Plaza-Zabala, E Martín-García, L de Lecea, R Maldonado, F Berrendero
Journal of Neuroscience 30 (6), 2300-2310, 2010
1382010
Sex steroid influence on cannabinoid CB1 receptor mRNA and endocannabinoid levels in the anterior pituitary gland
S Gonzalez, T Bisogno, T Wenger, J Manzanares, A Milone, F Berrendero, ...
Biochemical and biophysical research communications 270 (1), 260-266, 2000
1382000
Atypical location of cannabinoid receptors in white matter areas during rat brain development
J Romero, E Garcia‐Palomero, F Berrendero, L Garcia‐Gil, ...
Synapse 26 (3), 317-323, 1997
1311997
Time‐course of the cannabinoid receptor down‐regulation in the adult rat brain caused by repeated exposure to Δ9‐tetrahydrocannabinol
J Romero, F Berrendero, J Manzanares, A Pérez, J Corchero, JA Fuentes, ...
Synapse 30 (3), 298-308, 1998
1201998
Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease
I Lastres‐Becker, HH Hansen, F Berrendero, R De Miguel, ...
Synapse 44 (1), 23-35, 2002
1182002
Identification of endocannabinoids and cannabinoid CB1 receptor mRNA in the pituitary gland
S González, J Manzanares, F Berrendero, T Wenger, J Corchero, ...
Neuroendocrinology 70 (2), 137-145, 1999
1141999
Δ9‐tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice
GN Balerio, E Aso, F Berrendero, P Murtra, R Maldonado
European Journal of Neuroscience 20 (10), 2737-2748, 2004
1112004
Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen
J Romero, F Berrendero, A Perez-Rosado, J Manzanares, A Rojo, ...
Life sciences 66 (6), 485-494, 2000
1092000
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20